ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 5,720.00
+130.00 (2.33%)
At close: Sep 23, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 117.26 billion as of September 25, 2026. Its market cap has increased by 47.78% in one year.
Market Cap
117.26B
Enterprise Value
79.96B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
5,720.00
ChartMarket Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 117.26B, a decrease of -79.11%. That is a compound annual growth rate of -26.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 117.26B | -41.33% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kanaph Therapeutics | 158.54B |
| Ensol Biosciences | 146.64B |
| ISU Abxis | 143.94B |
| TiumBio | 134.42B |
| Y-Biologics | 122.93B |
| Prestige Biologics | 106.91B |
| Cell Biotech | 103.69B |
| AriBioLab | 96.51B |